Expression pattern of CAF markers and related genes, including ACTA2, CXCL12, FAP and TGF-β1 after treatment with cetuximab in HNSCC patients was measured, and an induction of CAF phenotype was noticed [115]. Here, TGFB1 is linked to head and neck squamous cell carcinoma.